Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Loviride is an experimental small molecule compound with the chemical formula C17H16Cl2N2O2 and a molecular weight of 351.227. It belongs to the class of alkyl phenylketones and features both dichlorophenyl and acetylanilino moieties. Loviride was investigated as a non-nucleoside reverse transcriptase inhibitor (NNRTI), primarily for its potential use in HIV therapy; however, it has not been approved for clinical use or advanced beyond early-stage research[1][3]. No current indications or approved uses are listed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on loviride.